CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-21 | Sheena Jonathan Director | Sale 10b5-1 | −125 | $413.05 | $52K | 218,584 |
| 2026-10-21 | Sheena Jonathan Director | Sale 10b5-1 | −255 | $415.67 | $106K | 218,329 |
| 2026-10-21 | Sheena Jonathan Director | Sale 10b5-1 | −165 | $416.67 | $69K | 218,164 |
| 2026-10-16 | Sheena Jonathan Director | Sale 10b5-1 | −215 | $399.34 | $86K | 8,785 |
| 2026-10-16 | Sheena Jonathan Director | Sale 10b5-1 | −280 | $401.29 | $112K | 8,505 |
| 2026-10-16 | Sheena Jonathan Director | Sale 10b5-1 | −90 | $404.25 | $36K | 8,415 |
| 2026-10-16 | Sheena Jonathan Director | Sale 10b5-1 | −50 | $405.15 | $20K | 8,365 |
| 2026-10-16 | Sheena Jonathan Director | Sale 10b5-1 | −35 | $406.63 | $14K | 8,330 |
| 2026-10-16 | Sheena Jonathan Director | Sale 10b5-1 | −80 | $409.36 | $33K | 8,250 |
| 2026-10-16 | Sheena Jonathan Director | Sale 10b5-1 | −142 | $398.95 | $57K | 8,858 |
| 2026-10-16 | Sheena Jonathan Director | Sale 10b5-1 | −280 | $400.68 | $112K | 8,578 |
| 2026-10-16 | Sheena Jonathan Director | Sale 10b5-1 | −60 | $401.62 | $24K | 8,518 |
| 2026-10-16 | Sheena Jonathan Director | Sale 10b5-1 | −90 | $403.70 | $36K | 8,428 |
| 2026-10-16 | Sheena Jonathan Director | Sale 10b5-1 | −80 | $406.06 | $32K | 8,348 |
| 2026-10-16 | Sheena Jonathan Director | Sale 10b5-1 | −98 | $409.34 | $40K | 8,250 |
| 2026-10-15 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Option exercise 10b5-1 | +50,000 | $10.41 | $521K | 2,169,394 |
| 2026-10-15 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −286 | $388.32 | $111K | 2,169,108 |
| 2026-10-15 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −714 | $389.84 | $278K | 2,168,394 |
| 2026-10-15 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −600 | $390.21 | $234K | 2,167,794 |
| 2026-10-15 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −300 | $391.58 | $117K | 2,167,494 |
Page 5 of 39 · 767 trades